Magnetic Resonance Imaging Improves Cerebrospinal Fluid Biomarkers in the Early Detection of Alzheimer's Disease
Mirosław Bryś(Eli Lilly (United States)), Mony J. de Leon(Cornell University), Pankaj Mehta, Remigiusz Switalski(New York University), Henry Rusinek(University at Buffalo, State University of New York), Kaj Blennow(Sahlgrenska University Hospital), Lidia Glodzik(NYU Langone Health), Susan De Santi, Kenneth Rich(New York University), Elizabeth Pirraglia(New York University), Domenico Praticò(University of Pennsylvania), Henrik Zetterberg(University of Wisconsin–Madison), Lisa Mosconi(Cornell University), Anders Wallin(Malmö University), Ray Zinkowski, Wai Hon Tsui(New York University), Byeong C. Kim(Chonnam National University Hospital)
Cited by 61
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k